Citation:
Ahmet I, Krawczyk M, Zhu W, Woo AY-H, Morrell C, Poosala S, Xiao R-P, Lakatta EG, Talan MI. Cardioprotective and survival benefits of long-term combined therapy with β2 adrenoreceptor (AR) agonist and β1 AR blocker in dilated cardiomyopathy postmyocardial infarction. Journal of Pharmacology and Experimental Therapeutics [Internet]. 2008;(2):491-499.